Press Releases :: Ligand Pharmaceuticals Incorporated (LGND)

Press Releases

Ligand Enters Global License Agreement with CURx Pharmaceuticals, Inc. for Captisol-EnabledTM Topiramate Injection

August 14, 2013

Ligand Reports Second Quarter Financial Results

August 1, 2013

Ligand Partner GlaxoSmithKline Receives Positive CHMP Opinion for REVOLADE™ in Thrombocytopenia Associated with Chronic Hepatitis C Infection

July 26, 2013

Ligand Receives Orphan Designation for Captisol-EnabledTM Topiramate Injection

July 26, 2013

Ligand Signs License Agreement with Ethicor for Oral Lasofoxifene

July 24, 2013

Ligand Signs Global License Agreement with Azure for Lasofoxifene

July 22, 2013

Ligand to Report Second Quarter Results on August 1st

July 16, 2013

Ligand Announces Positive Preclinical Data for Glucagon Program in Model of Type 1 Diabetes

June 24, 2013

Ligand Raises Ownership Limit for BVF Partners to 25% of Shares Outstanding

June 20, 2013

Ligand Provides New Corporate Presentation at Investor Conference

May 29, 2013